Defence Therapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is July - June.

Millions CAD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2019
Period Ending	Apr '26 Apr 28, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	2020 - 2019
Market Capitalization	39	38	34	128	73	245	Upgrade
Market Cap Growth	-31.60%	13.68%	-73.58%	74.18%	-70.15%	-	Upgrade
Enterprise Value	40	38	35	126	72	239	Upgrade
Last Close Price	0.52	0.70	0.74	2.92	2.00	7.05	Upgrade
PB Ratio	-32.11	-30.50	-9.40	81.44	-188.95	44.72	Upgrade
P/TBV Ratio	-	-	-	83.51	-	45.09	Upgrade
Debt / Equity Ratio	-1.22	-1.20	-0.49	1.12	-	-	Upgrade
Net Debt / Equity Ratio	-0.44	-0.22	-0.47	-0.67	1.31	-0.99	Upgrade
Net Debt / EBITDA Ratio	-0.13	-0.09	-0.13	0.16	-	-	Upgrade
Net Debt / FCF Ratio	-0.11	-0.08	-0.38	0.14	0.08	2.38	Upgrade
Quick Ratio	1.06	0.49	0.04	13.35	0.48	45.19	Upgrade
Current Ratio	1.08	0.50	0.05	15.58	0.61	45.51	Upgrade
Return on Equity (ROE)	-	-	-	-1147.59%	-288.03%	-77.80%	Upgrade
Return on Assets (ROA)	-288.45%	-187.25%	-397.30%	-190.91%	-143.66%	-46.96%	Upgrade
Return on Capital Employed (ROCE)	-1551.30%	254.00%	356.40%	-196.10%	1876.80%	-51.50%	Upgrade
Earnings Yield	-11.03%	-9.19%	-39.15%	-5.30%	-10.03%	-1.17%	Upgrade
FCF Yield	-12.61%	-8.88%	-13.33%	-6.05%	-8.25%	-0.93%	Upgrade
Buyback Yield / Dilution	-19.06%	-11.64%	-12.54%	-9.93%	-35.65%	-2719.76%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.